Cardiovascular and Renal Morbidity in Takayasu Arteritis: A Population‐Based Retrospective Cohort Study From the United Kingdom
Arthritis & Rheumatology2020Vol. 73(3), pp. 504–511
Citations Over TimeTop 10% of 2020 papers
Ruchika Goel, Joht Singh Chandan, Rasiah Thayakaran, Nicola J. Adderley, Krishnarajah Nirantharakumar, Lorraine Harper
Abstract
Cardiovascular morbidity was increased among patients with TAK receiving primary care services in the UK. Treatment with statins and antiplatelet agents in these patients was suboptimal.
Related Papers
- → Efficacy and safety of lung recruitment in pediatric patients with acute lung injury(2010)56 cited
- → Hemoglobin Levels Across the Pediatric Critical Care Spectrum: A Point Prevalence Study*(2018)8 cited
- → Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia(2022)3 cited
- [Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study].(2023)
- 效果热门在有干燥眼睛疾病的病人的角膜的内皮细胞层上的 0.05% cyclosporine A(2013)